Stemtech (STEK) Gains from Investment Securities (2020 - 2023)
Stemtech's (STEK) quarterly Gains from Investment Securities came in at $1.6 million in Q4 2023, up 651.66% quarter-over-quarter from $216000.0 in Q2 2020.
Stemtech (STEK) Gains from Investment Securities (2020 - 2023) Analysis & Trends
Stemtech has disclosed Gains from Investment Securities across 2 years of filings, most recently posting $1.6 million for Q4 2023.
- Gains from Investment Securities for Q4 2023 came in at $1.6 million, changed N/A year-over-year; the trailing twelve-month figure through Sep 2024 was $1.6 million (changed N/A YoY), and the FY2023 annual result was $1.6 million, changed N/A from the prior year.
- Gains from Investment Securities came in at $1.6 million for Q4 2023 at Stemtech, up from $216000.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $1.6 million in Q4 2023 to a low of $216000.0 in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn |
| 10 | Stemtech | - | - | 354,677.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 1.62 Mn |
| Dec 31, 2023 | 1.62 Mn |
| May 31, 2020 | 216,000.00 |
| May 31, 2020 | 216,000.00 |